Freshfields is advising Moderna on its ten-year agreement with the State of Victoria to establish a state-of-the-art, domestic mRNA vaccine manufacturing facility at Monash University, where it will produce up to 100 million mRNA respiratory vaccine doses annually. Construction is expected to commence before the end of 2022, with a target date of the end […]
The post Freshfields Advises Moderna on Its Ten-Year Agreement With Monash University and the State of Victoria to Produce mRNA Vaccines appeared first on Legal Desire.